Michael Robert Martin - Net Worth and Insider Trading
Michael Robert Martin Net Worth
The estimated net worth of Michael Robert Martin is at least $838,727 dollars as of 2024-12-14. Michael Robert Martin is the Chief Business Officer of Aurinia Pharmaceuticals Inc and owns about 89,512 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $838,727. Details can be seen in Michael Robert Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Robert Martin has not made any transactions after 2022-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Robert Martin
Michael Robert Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Robert Martin owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Michael Robert Martin’s form 4 insider trades.
Insider Ownership Summary of Michael Robert Martin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2022-11-07 | Chief Business Officer |
Michael Robert Martin Latest Holdings Summary
Michael Robert Martin currently owns a total of 1 stock. Michael Robert Martin owns 89,512 shares of Aurinia Pharmaceuticals Inc (AUPH) as of November 7, 2022, with a value of $838,727.
Latest Holdings of Michael Robert Martin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2022-11-07 | 89,512 | 9.37 | 838,727 |
Holding Weightings of Michael Robert Martin
Michael Robert Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Robert Martin has made a total of 12 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 11 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the acquisition of 30,000 shares on November 7, 2022, which cost Michael Robert Martin around $154,800.
Insider Trading History of Michael Robert Martin
- 1
Michael Robert Martin Trading Performance
GuruFocus tracks the stock performance after each of Michael Robert Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Robert Martin is 78.02%. GuruFocus also compares Michael Robert Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Robert Martin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Robert Martin's insider trading performs compared to the benchmark.
Performance of Michael Robert Martin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.92 | | | | | |
| Relative Return to S&P 500(%) | -11.26 | | | | | |
Michael Robert Martin Ownership Network
Ownership Network List of Michael Robert Martin
Ownership Network Relation of Michael Robert Martin
Michael Robert Martin Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Michael Robert Martin is the Chief Business Officer of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Michael Robert Martin made no insider transaction in Aurinia Pharmaceuticals Inc (AUPH). Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net purchase of 1,200,000 shares made by Kevin C Tang .
In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 1,200,000 shares, with a net purchase of 1,190,202 shares. During the past 18 months, 373,927 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 1,200,000 shares were bought by its insiders, resulting in a net purchase of 826,073 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Michael Robert Martin Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Robert Martin. You might contact Michael Robert Martin via mailing address: #1203-4464 Markham Street, Victoria A1 Bc V8z7x8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
